ArticleScientific reports2026

Myricetin alleviates testosterone-induced benign prostatic hyperplasia by attenuating inflammation, oxidative stress, apoptosis and androgen signaling.

Ghada Alomari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.